Medical - Healthcare Information Services
Compare Stocks
2 / 10Stock Comparison
TEM vs ORCL
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
TEM vs ORCL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Healthcare Information Services | Software - Infrastructure |
| Market Cap | $9.33B | $557.72B |
| Revenue (TTM) | $1.36B | $64.08B |
| Net Income (TTM) | $-303M | $16.21B |
| Gross Margin | 71.7% | 66.4% |
| Operating Margin | -18.7% | 30.8% |
| Forward P/E | — | 25.9x |
| Total Debt | $816M | $104.10B |
| Cash & Equiv. | $605M | $10.79B |
TEM vs ORCL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 24 | May 26 | Return |
|---|---|---|---|
| Tempus AI, Inc. (TEM) | 100 | 152.9 | +52.9% |
| Oracle Corporation (ORCL) | 100 | 137.4 | +37.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TEM vs ORCL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TEM is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 83.4%, EPS growth 69.3%, 3Y rev CAGR 58.3%
- Lower volatility, beta 2.77, current ratio 3.13x
- 83.4% revenue growth vs ORCL's 8.4%
ORCL carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 18 yrs, beta 1.59, yield 0.9%
- 423.1% 10Y total return vs TEM's 32.9%
- Beta 1.59, yield 0.9%, current ratio 0.75x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 83.4% revenue growth vs ORCL's 8.4% | |
| Quality / Margins | 25.3% margin vs TEM's -22.2% | |
| Stability / Safety | Beta 1.59 vs TEM's 2.77 | |
| Dividends | 0.9% yield; 18-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +32.7% vs TEM's +2.5% | |
| Efficiency (ROA) | 8.1% ROA vs TEM's -14.6%, ROIC 12.8% vs -40.4% |
TEM vs ORCL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TEM vs ORCL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — TEM and ORCL each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ORCL is the larger business by revenue, generating $64.1B annually — 47.0x TEM's $1.4B. ORCL is the more profitable business, keeping 25.3% of every revenue dollar as net income compared to TEM's -22.2%. On growth, TEM holds the edge at +36.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.4B | $64.1B |
| EBITDAEarnings before interest/tax | -$271M | $26.5B |
| Net IncomeAfter-tax profit | -$303M | $16.2B |
| Free Cash FlowCash after capex | -$208M | -$24.7B |
| Gross MarginGross profit ÷ Revenue | +71.7% | +66.4% |
| Operating MarginEBIT ÷ Revenue | -18.7% | +30.8% |
| Net MarginNet income ÷ Revenue | -22.2% | +25.3% |
| FCF MarginFCF ÷ Revenue | -15.3% | -38.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +36.1% | +21.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -77.5% | +24.5% |
Valuation Metrics
TEM leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $9.3B | $557.7B |
| Enterprise ValueMkt cap + debt − cash | $9.5B | $651.0B |
| Trailing P/EPrice ÷ TTM EPS | -37.94x | 44.70x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 25.92x |
| PEG RatioP/E ÷ EPS growth rate | — | 6.30x |
| EV / EBITDAEnterprise value multiple | — | 27.30x |
| Price / SalesMarket cap ÷ Revenue | 7.33x | 9.72x |
| Price / BookPrice ÷ Book value/share | 18.98x | 26.51x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
ORCL leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ORCL delivers a 56.3% return on equity — every $100 of shareholder capital generates $56 in annual profit, vs $-70 for TEM. TEM carries lower financial leverage with a 1.66x debt-to-equity ratio, signaling a more conservative balance sheet compared to ORCL's 4.96x. On the Piotroski fundamental quality scale (0–9), ORCL scores 6/9 vs TEM's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -70.2% | +56.3% |
| ROA (TTM)Return on assets | -14.6% | +8.1% |
| ROICReturn on invested capital | -40.4% | +12.8% |
| ROCEReturn on capital employed | -18.8% | +14.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 1.66x | 4.96x |
| Net DebtTotal debt minus cash | $211M | $93.3B |
| Cash & Equiv.Liquid assets | $605M | $10.8B |
| Total DebtShort + long-term debt | $816M | $104.1B |
| Interest CoverageEBIT ÷ Interest expense | -1.08x | 5.44x |
Total Returns (Dividends Reinvested)
ORCL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ORCL five years ago would be worth $25,324 today (with dividends reinvested), compared to $13,292 for TEM. Over the past 12 months, ORCL leads with a +32.7% total return vs TEM's +2.5%. The 3-year compound annual growth rate (CAGR) favors ORCL at 27.2% vs TEM's 10.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -14.2% | -0.4% |
| 1-Year ReturnPast 12 months | +2.5% | +32.7% |
| 3-Year ReturnCumulative with dividends | +32.9% | +105.9% |
| 5-Year ReturnCumulative with dividends | +32.9% | +153.2% |
| 10-Year ReturnCumulative with dividends | +32.9% | +423.1% |
| CAGR (3Y)Annualised 3-year return | +10.0% | +27.2% |
Risk & Volatility
ORCL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ORCL is the less volatile stock with a 1.59 beta — it tends to amplify market swings less than TEM's 2.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ORCL currently trades 56.1% from its 52-week high vs TEM's 51.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.77x | 1.59x |
| 52-Week HighHighest price in past year | $104.32 | $345.72 |
| 52-Week LowLowest price in past year | $41.73 | $134.57 |
| % of 52W HighCurrent price vs 52-week peak | +51.3% | +56.1% |
| RSI (14)Momentum oscillator 0–100 | 54.3 | 64.4 |
| Avg Volume (50D)Average daily shares traded | 5.2M | 26.2M |
Analyst Outlook
ORCL leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates TEM as "Buy" and ORCL as "Buy". Consensus price targets imply 55.9% upside for TEM (target: $83) vs 32.6% for ORCL (target: $257). ORCL is the only dividend payer here at 0.85% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $83.43 | $257.19 |
| # AnalystsCovering analysts | 12 | 86 |
| Dividend YieldAnnual dividend ÷ price | — | +0.9% |
| Dividend StreakConsecutive years of raises | 0 | 18 |
| Dividend / ShareAnnual DPS | — | $1.65 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | +0.3% |
ORCL leads in 4 of 6 categories (Profitability & Efficiency, Total Returns). TEM leads in 1 (Valuation Metrics). 1 tied.
TEM vs ORCL: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is TEM or ORCL a better buy right now?
For growth investors, Tempus AI, Inc.
(TEM) is the stronger pick with 83. 4% revenue growth year-over-year, versus 8. 4% for Oracle Corporation (ORCL). Oracle Corporation (ORCL) offers the better valuation at 44. 7x trailing P/E (25. 9x forward), making it the more compelling value choice. Analysts rate Tempus AI, Inc. (TEM) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — TEM or ORCL?
Over the past 5 years, Oracle Corporation (ORCL) delivered a total return of +153.
2%, compared to +32. 9% for Tempus AI, Inc. (TEM). Over 10 years, the gap is even starker: ORCL returned +423. 1% versus TEM's +32. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — TEM or ORCL?
By beta (market sensitivity over 5 years), Oracle Corporation (ORCL) is the lower-risk stock at 1.
59β versus Tempus AI, Inc. 's 2. 77β — meaning TEM is approximately 74% more volatile than ORCL relative to the S&P 500. On balance sheet safety, Tempus AI, Inc. (TEM) carries a lower debt/equity ratio of 166% versus 5% for Oracle Corporation — giving it more financial flexibility in a downturn.
04Which is growing faster — TEM or ORCL?
By revenue growth (latest reported year), Tempus AI, Inc.
(TEM) is pulling ahead at 83. 4% versus 8. 4% for Oracle Corporation (ORCL). On earnings-per-share growth, the picture is similar: Tempus AI, Inc. grew EPS 69. 3% year-over-year, compared to 17. 0% for Oracle Corporation. Over a 3-year CAGR, TEM leads at 58. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — TEM or ORCL?
Oracle Corporation (ORCL) is the more profitable company, earning 21.
7% net margin versus -19. 3% for Tempus AI, Inc. — meaning it keeps 21. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ORCL leads at 30. 8% versus -18. 8% for TEM. At the gross margin level — before operating expenses — ORCL leads at 70. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is TEM or ORCL more undervalued right now?
Analyst consensus price targets imply the most upside for TEM: 55.
9% to $83. 43.
07Which pays a better dividend — TEM or ORCL?
In this comparison, ORCL (0.
9% yield) pays a dividend. TEM does not pay a meaningful dividend and should not be held primarily for income.
08Is TEM or ORCL better for a retirement portfolio?
For long-horizon retirement investors, Oracle Corporation (ORCL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (0.
9% yield, +423. 1% 10Y return). Tempus AI, Inc. (TEM) carries a higher beta of 2. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ORCL: +423. 1%, TEM: +32. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between TEM and ORCL?
These companies operate in different sectors (TEM (Healthcare) and ORCL (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: TEM is a small-cap high-growth stock; ORCL is a large-cap quality compounder stock. ORCL pays a dividend while TEM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.